Cargando…
The effect of MDR-1 gene expression on outcome in acute myeloblastic leukaemia.
Resistance to cytotoxic agents may be encountered during the treatment of acute myeloblastic leukaemia (AML). P-glycoprotein encoded by the MDR-1 gene has been implicated as a potential drug resistance mechanism in leukaemic cells. In recent years, many data have been accrued concerning the expressi...
Autores principales: | Holmes, J. A., West, R. R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968682/ https://www.ncbi.nlm.nih.gov/pubmed/7905280 |
Ejemplares similares
-
A Case of Acute Myeloblastic Leukæmia
por: Fleming, Robert A., et al.
Publicado: (1924) -
Granulocyte function in myeloblastic leukaemia.
por: Wilkinson, P. M., et al.
Publicado: (1975) -
Proceedings: Surface immunological markers in acute myeloblastic leukaemia.
por: Taylor, G. M., et al.
Publicado: (1975) -
Adiponectin in relation to childhood myeloblastic leukaemia
por: Petridou, E, et al.
Publicado: (2006) -
Proceedings: Cell mediated cytotoxicity (CMC) in patients with acute myeloblastic leukaemia receiving immunotherapy.
por: Taylor, G. M., et al.
Publicado: (1975)